Regeneron Pharmaceuticals Inc (REGN) institutional holders · P/E 14, rev $4.29B
Regeneron Pharmaceuticals Inc 13F cache, top 7 holders by reported value.
| Holder | Shares | Value | Report |
|---|---|---|---|
| VANGUARD GROUP INC | 8,070,035 | $6.23T | 2025-12-31 |
| BlackRock Finance, Inc. | 3,219,606 | $3.38T | 2024-06-30 |
| STATE STREET CORP | 4,834,688 | $3.01T | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 762,859 | $589.42B | 2026-03-31 |
| FMR LLC | 355,858 | $221.89B | 2026-06-30 |
| CITADEL ADVISORS LLC | 213,700 | $165.11B | 2026-03-31 |
| Bridgewater Associates, LP | 51,333 | $32.01B | 2026-06-30 |
FAQ
What is REGN P/E and revenue?
Regeneron Pharmaceuticals Inc (REGN) P/E 14, rev $4.29B.
Who owns REGN?
Regeneron Pharmaceuticals Inc cache lists 7 13F holders by reported market value.
Not investment advice. Cached rows, not a live tape.